David Ellenberger

Hannover, NI, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Higher disease reactivation risk in women after fingolimod withdrawal.

Higher disease reactivation risk in women after fingolimod withdrawal.

Journal: Acta neuropathologica communications

Published: March 17, 2026

Real-world data on the prevalence and therapy of symptomatic bladder dysfunction in people with multiple sclerosis.

Real-world data on the prevalence and therapy of symptomatic bladder dysfunction in people with multiple sclerosis.

Journal: Therapeutic advances in neurological disorders

Published: January 07, 2026

Paediatric-onset multiple sclerosis: demographics, symptoms and disease progression.

Paediatric-onset multiple sclerosis: demographics, symptoms and disease progression.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: May 15, 2025

Age-related differences in switching highly effective disease-modifying therapy in patients with multiple sclerosis.

Age-related differences in switching highly effective disease-modifying therapy in patients with multiple sclerosis.

Journal: Journal of neurology

Published: May 08, 2025

From routine to selective: how updated MRI guidelines reshape gadolinium use in Germany.

From routine to selective: how updated MRI guidelines reshape gadolinium use in Germany.

Journal: Neurological research and practice

Published: March 12, 2025

Generalisability of Phase III Clinical Trials Using the Example of Two German Multiple Sclerosis Registries

Generalisability of Phase III Clinical Trials Using the Example of Two German Multiple Sclerosis Registries

Journal: Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))

Published: February 15, 2025

MS treatment trends before, during, and after the COVID-19 pandemic: insights from the German MS Register.

MS treatment trends before, during, and after the COVID-19 pandemic: insights from the German MS Register.

Journal: Journal of neurology

Published: January 05, 2025

Symptoms Prior to Diagnosis of Multiple Sclerosis in Individuals Younger Than 18 Years.

Symptoms Prior to Diagnosis of Multiple Sclerosis in Individuals Younger Than 18 Years.

Journal: JAMA network open

Published: December 27, 2024

Prediction Intervals for Overdispersed Poisson Data and Their Application in Medical and Pre-Clinical Quality Control.

Prediction Intervals for Overdispersed Poisson Data and Their Application in Medical and Pre-Clinical Quality Control.

Journal: Pharmaceutical statistics

Published: March 11, 2024

Persons with multiple sclerosis older than 55 years: an analysis from the German MS registry.

Persons with multiple sclerosis older than 55 years: an analysis from the German MS registry.

Journal: Journal of neurology

Published: February 13, 2024

Occurrence and Risk Factors of Relapse Activity after Vaccination against COVID-19 in People with Multiple Sclerosis: 1-Year Follow-Up Results from a Nationwide Longitudinal Observational Study.

Occurrence and Risk Factors of Relapse Activity after Vaccination against COVID-19 in People with Multiple Sclerosis: 1-Year Follow-Up Results from a Nationwide Longitudinal Observational Study.

Journal: Vaccines

Published: November 08, 2023

The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across Europe.

The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across Europe.

Journal: Therapeutic advances in neurological disorders

Published: August 02, 2023

Showing 1-12 of 61

Last Updated: 09/26/2026